Atlas Trials

The Effect of Dexamethasone 12 mg vs 6 mg on Thromboembolic Events in Patients With Critical COVID-19

Clinical trial NCT05195242 · COMPLETED

Trial details

NCT number
NCT05195242
Sponsor
Karolinska Institutet
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
COVID-19Thrombosis EmbolismBleeding
Start date
2020-08-27
Primary completion
2021-06-20
Enrollment
445

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.